Streetbeat News

Stock Prices

AR

Antero Resources (NYSE:AR) has been analyzed by 7 analysts, showing a mix of bullish to bearish sentiments. The average 12-month price target is $28.00, down 7.68% from the previous target. Analyst actions include both upgrades and downgrades, reflecting varying perspectives on the company's performance. Antero Resources, engaged in natural gas and liquids production, faces challenges with lower market capitalization, revenue decline of -38.57%, and below-average profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:01 pm

PLXS

Analysts have diverse opinions on Plexus (NASDAQ:PLXS), with recent ratings ranging from bullish to indifferent. The average 12-month price target is now $109.8, down from $111.50. Plexus faces revenue challenges with a -10.18% decline as of December 31, 2023, but outperforms in net margin, ROE, and ROA. The company's debt management is also noted positively.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:00 pm

TYL

Tyler Technologies (NYSE:TYL) has received mixed analyst ratings over the past three months, with a total of 10 ratings ranging from bullish to bearish. The average 12-month price target for TYL has increased by 5.3% to $491.5. Analyst actions include maintaining, raising, and announcing ratings, with price targets adjusted accordingly. Tyler Technologies, a provider of software solutions for local government entities, has shown a revenue growth of 6.35% as of December 31, 2023, but trails behind industry peers in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:00 pm

MOH

Over the past 20 years, Molina Healthcare (NYSE:MOH) has delivered an average annual return of 15.54%, outperforming the market by 7.64% annually. With a current market capitalization of $22.88 billion, a $1000 investment in MOH 20 years ago would be worth $17,980.73 today.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:00 pm

BC

Over the past 15 years, Brunswick (NYSE:BC) has produced an average annual return of 26.02%, outperforming the market by 12.45% on an annualized basis. A $100 investment in BC 15 years ago would be worth $2,967.97 today. Brunswick's market capitalization currently stands at $6.10 billion.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:00 pm

ADAUSD

Cardano (CRYPTO: ADA) has seen a 3.9% decrease in price over the last 24 hours, falling to $0.72, despite a 6.0% gain over the past week. The trading volume has decreased by 6.0%, while the circulating supply has increased by 0.56%, reaching 35.18 billion. ADA's market cap ranking is currently #9 at $25.48 billion.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 7:00 pm

BBAI

BigBear.ai, Inc. (NYSE:BBAI) reported Q4 financial results below expectations, with a loss of 14 cents per share against an estimated 5 cents, and sales of $40.563 million missing the $42.755 million forecast. Despite a year-over-year sales increase of 0.51%, the stock dropped. The company also completed the acquisition of Pangiam Intermediate Holdings. After a surge due to Nvidia's earnings, BBAI shares are still up nearly 50% over the past month but fell 31.7% to $2.56 following the earnings report.

Portfolio Pulse from Erica Kollmann

March 08, 2024 | 6:58 pm

SWBI

Craig-Hallum analyst Steve Dyer upgrades Smith & Wesson Brands (SWBI) from Hold to Buy and increases the price target from $14 to $18.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 6:52 pm

ALXO

ALX Oncology Holdings (NASDAQ:ALXO) reported a Q4 2023 EPS loss of $(0.93), missing consensus estimates. Despite sufficient funds to operate into early 2026 and promising interim Phase 2 data for its cancer treatment, evorpacept, Stifel downgraded the stock from Buy to Hold. The downgrade reflects concerns over the limited market size for HER2+ gastric cancer and uncertainties in development paths for other cancers. ALXO shares dropped 3.51% to $15.67.

Portfolio Pulse from Vandana Singh

March 08, 2024 | 6:48 pm

BLK

CDIO

BlackRock, Inc. (NYSE:BLK) is set to acquire SpiderRock Advisors, a provider of customized option overlay strategies in the U.S. wealth market, expanding its offerings in personalized separately managed accounts (SMAs). The financial terms were not disclosed, but the deal is not expected to materially impact BlackRock's earnings. This follows BlackRock's minority investment in SpiderRock Advisors in 2021 and a recent minor stake acquisition in Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO). SpiderRock Advisors managed about $4.8 billion in client assets as of February 2024. The acquisition is anticipated to close in the second quarter of 2024.

Portfolio Pulse from Nabaparna Bhattacharya

March 08, 2024 | 6:46 pm